Sign in
4

Changes in Ownership

DEXCOM INC Filed Acc 0001093557-24-000064

EVP Strategy and Corporate Dev sold 1,990 shares at $137.81 ($274,242)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Dolan Matthew Vincent EVP Strategy and Corporate Dev 2024-04-15 Sale 10b5-1 −1,990 $137.81 $274,242 42,377 D: show line 1 in the form
Open-market sales · 1,990 sh · avg $137.81 · $274,242
Loading xslF345X05/edgardoc.xml…